News and Press Releases
At MD&M Minneapolis, TekniPlex Healthcare to Highlight Concept-to-Commercialization Capabilities for Class III Implantable Devices and Delivery Systems
Comprehensive services punctuated by precision, tight-tolerance metalworking expertise and injection molding solutions; company also will display range of medical tubing such as catheter-based systems, as well as select medical device...
Category: Drug Delivery, Manufacturing and Packing, Other
Posted: September 18, 2024
Industrielaan 37 B-9320 Erembodegem Belgium Tel: +32 (0)53 650711 VAT 0425.537.515
CPHI Annual Report 2024: CPHI Milan Report predicts BLA and Tides approvals will surpass small molecules within the next three years
Bio and Tides predicted to be the fastest growing modality for CDMOs over the next five years 12 September 2024 – Milan, Italy – Ahead of CPHI Milan – the...
Category: Pharmaceutical
Posted: September 12, 2024
Rentschler Biopharma introduces new lentiviral vector manufacturing toolbox for advanced therapies
Expanded service offering client ready at company’s site in Stevenage, UK Offering includes process development and cGMP manufacturing services, as well as complementary in-house analytical and regulatory support for lentiviral...
Category: BioManufacturing, Pharmaceutical Contractors
Posted: September 5, 2024
Valneva Scotland Receives Prestigious Award for Health and Safety Excellence
8 August 2024 -- Scotland, UK -- Scotland's largest vaccine producer, Valneva Scotland Ltd, based in Livingston, has achieved an esteemed Silver Award for health and safety from the Royal...
Category: BioManufacturing, Pharmaceutical
Posted: August 9, 2024
Europe 2024 World Vaccine Congress
23 July 2024, Barcelona, Spain – World Vaccine Congress Europe will host 3000+ attendees, 280 speakers, 150+ exhibitors and plenty of start-ups over the course of 4 days. With a...
Category: Drug Delivery, Other
Posted: July 23, 2024
ViroCell Biologics signs Master Services Agreement with prominent NCI-designated cancer centre
MSA enables collaboration on full suite of ViroCell’s viral vector manufacturing services to accelerate the cancer centre’s clinical development of novel gene-modified cell therapies Agreement follows ViroCell’s successful GMP manufacture...
Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: July 22, 2024
Just – Evotec Biologics selected by US Department of Defence for Manufacturing Optimisation Programme
Just – Evotec Biologics will deliver an ultra-rapid, cost-efficient biotherapeutics manufacturing platform solution for the DOD’s manufacturing optimisation programme Manufacturing solution includes seamless integration of accelerated mAb drug development into...
Category: BioManufacturing
Posted: July 10, 2024
Just – Evotec Biologics, Inc. 401 Terry Avenue North Seattle, WA 98109, US
Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz
Just – Evotec Biologics expands partnership with Sandoz for development and commercial manufacturing of biosimilars Additional biosimilars potentially to be added to Sandoz development pipeline Further guarantees for Sandoz long-term...
Category: BioManufacturing, Biotechnology
Posted: July 10, 2024
Just – Evotec Biologics, Inc. 401 Terry Avenue North Seattle, WA 98109, US
Formycon receives FDA approval for FYB203/ AHZANTIVE) (aflibercept-mrbb), a biosimilar to Eylea
1 July 2024, Planegg-Martinsried, Germany - Formycon AG (FSE: FYB, “Formycon”) and its licencing partnerKlinge Biopharma GmbH ("Klinge") jointly announce that the U.S. Food and Drug Administration ("FDA")approved FYB203/AHZANTIVE (aflibercept-mrbb),...
Category: Pharmaceutical
Posted: July 1, 2024
Celonic Inaugurates “Next Generation” Biologics Development Centre (BDC) and Pilot Plant in Basel, Switzerland
The Celonic Group, a “Pure Play” Biologics contract development and manufacturing organisation (CDMO), expands process development and optimisation services in Basel Investment builds on “Next Generation” bioprocessing capability and pilot...
Category: BioManufacturing, Pharmaceutical
Posted: June 18, 2024
Primrose Bio Announces Investment from 1315 Capital to Advance Manufacturing Solutions for Next-Generation Therapeutics
June 17 2024 - California, US – Primrose Bio, Inc. (“Primrose,” the “company”), a company focused on developing and licensing its manufacturing technologies for nucleic acids and proteins used in...
Category: Biotechnology, Drug Delivery, Other
Posted: June 18, 2024
Primrose Bio, 10790 Roselle Street, San Diego, CA 92121 United States
Formycon reports on the results of the annual general meeting
Management provides detailed report on financial year 2023 and current company performance. Shareholders approve all agenda items and formally approve the acts of the members of the management board and...
Category: BioManufacturing
Posted: June 13, 2024
Freudenberg Medical Expands Coatings Business with New Production Facility
Investment of more than $50m to meet growing global demand for drug and hydrophilic coatings for medical devices and components Manufacturing footprint tripled with new 130,000sqft facility in the Aachen...
Category: Manufacturing and Packing, Other, Pharmaceutical
Posted: June 11, 2024
Vetter announces plans to expand its capacity in the US and Germany
Leading globally operating CDMO outlines location and design of new manufacturing sites to meet increasing customer demands Vetter Advisory Board decides on strategic path forward for further independent and sustainable...
Category: Manufacturing and Packing, Other, Pharmaceutical
Posted: June 6, 2024
Bionova Scientific announces plans for new Plasmid DNA GMP facility
Facility in The Woodlands, Texas, US, to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics in Q1/2025 3 June 2024 -- California, US --...
Category: BioManufacturing, Manufacturing and Packing, Pharmaceutical
Posted: June 3, 2024
